radon mitigation system
Otherstandard radon mitigation system used to reduce radon in homes
NCT Number: NCT06706336
To determine if radon mitigation can improve asthma
Trial opening soon.
Get Notified5 year–25 year
All sexes
Interventional
Not applicable
We will conduct a randomized, double-blind, sham controlled trial to investigate the efficacy of radon mitigation in the homes of susceptible individuals to provide evidence for health benefits by improving indoor air quality. The trial will include 180 children with asthma. We will install a standard radon specific mitigation system in the participant's home. Health outcomes will be followed over 48 weeks to determine the outcomes of the intervention versus inactive (sham) control.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Use of an asthma medication during the prior 12 months, report of asthma symptoms over the prior 12 months (wheezing/whistling in the chest)(3)
OR
One or more asthma-related hospitalization, emergency room visit
OR
Unscheduled clinic or urgent care facility visit resulting in a burst of systemic steroids (3 days or more of prednisone or equivalent; 1 or more doses of dexamethasone) in the previous 12 months
Exclusion criteria
standard radon mitigation system used to reduce radon in homes
inactive radon mitigation system
Time frame: past 2 weeks
Number of Days With Asthma Symptoms
Contact information is provided by the study sponsor or research team.
Boston Children's Hospital
Other
Acronym: ROME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728578
Asthma, Bronchial Diseases
Damietta, Egypt
View Trial DetailsNCT05776927
Asthma, Bronchial Diseases
View Trial DetailsNCT07712393
Asthma, Bronchial Diseases
View Trial DetailsNCT07654842
Asthma, Bronchial Diseases
Skokie, Illinois, United States
View Trial Details